The American owner of the LloydsPharmacy chain is in talks to sell one of Britain’s biggest drug retail and wholesale groups amid warnings about the industry’s future financial viability.
Sky News has learnt that McKesson, a New York-listed group with a market value of $29bn, has hired bankers to explore a sale of its UK operation.
City sources said that bankers at Barclays were working with McKesson on a disposal of the business and had begun contacting prospective bidders in recent weeks.
